- Home
- BMRN vs XP Comparison
BMRN vs XP Comparison
Compare BMRN & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- XP
- Stock Information
- Founded
- BMRN 1996
- XP 2001
- Country
- BMRN United States
- XP Cayman Islands
- Employees
- BMRN N/A
- XP N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- XP Investment Bankers/Brokers/Service
- Sector
- BMRN Health Care
- XP Finance
- Exchange
- BMRN Nasdaq
- XP Nasdaq
- Market Cap
- BMRN 12.1B
- XP 9.8B
- IPO Year
- BMRN 1999
- XP 2019
- Fundamental
- Price
- BMRN $58.07
- XP $19.36
- Analyst Decision
- BMRN Buy
- XP Buy
- Analyst Count
- BMRN 22
- XP 6
- Target Price
- BMRN $93.43
- XP $22.00
- AVG Volume (30 Days)
- BMRN 2.2M
- XP 8.5M
- Earning Date
- BMRN 05-01-2025
- XP 05-20-2025
- Dividend Yield
- BMRN N/A
- XP 3.36%
- EPS Growth
- BMRN 152.82
- XP 15.23
- EPS
- BMRN 2.71
- XP 1.51
- Revenue
- BMRN $2,950,227,000.00
- XP $2,886,046,386.00
- Revenue This Year
- BMRN $12.27
- XP $19.79
- Revenue Next Year
- BMRN $10.08
- XP $12.65
- P/E Ratio
- BMRN $21.47
- XP $12.80
- Revenue Growth
- BMRN 19.36
- XP 9.27
- 52 Week Low
- BMRN $52.93
- XP $10.82
- 52 Week High
- BMRN $94.85
- XP $20.39
- Technical
- Relative Strength Index (RSI)
- BMRN 41.32
- XP 74.59
- Support Level
- BMRN $57.27
- XP $18.04
- Resistance Level
- BMRN $59.12
- XP $19.85
- Average True Range (ATR)
- BMRN 1.40
- XP 0.55
- MACD
- BMRN 0.06
- XP -0.00
- Stochastic Oscillator
- BMRN 18.34
- XP 78.00
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.